The Canadian Government Proposes Amendments to the Regulation of Drug Pricing

By Richard Y. Cheung, Ph.D., Toronto, Fasken Martineau DuMoulin

Due to concerns about the growing percentage of the health care budget allotted to drug spending in Canada and the relative drug prices in Canada compared to other developed countries, the Canadian government is proposing changes to the way in which prices for patented drugs are regulated …

Read or download the full article below.